New pill aims to tame hepatitis b with dual attack
Disease control
Recruiting now
This study tests azvudine tablets in 120 adults with chronic hepatitis B to see if the drug can control the virus long-term. The approach combines antiviral action with immune system activation. Participants take the medication daily for 12 months, and researchers monitor viral l…
Phase: PHASE3 • Sponsor: Zhigang Ren • Aim: Disease control
Last updated May 15, 2026 11:53 UTC